BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Breaking News: BioWorld Science 2025 Year in Review
Breaking News: BioWorld 2025 Year in Review
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Approval of Lemtrada for relapsing remitting MS recommended in Europe
July 2, 2013
Drisapersen receives FDA breakthrough therapy designation
July 2, 2013
FDA approves Exelon patch to treat all stages of Alzheimer's disease
July 2, 2013
Novel BACE1 inhibitors patented by Janssen Pharmaceutica
July 1, 2013
Novel drug candidate for L-Dopa-induced dyskinesia
July 1, 2013
New beta-secretase inhibitors disclosed by Janssen Pharmaceutica
June 28, 2013
Researchers from Roche present a new clinical candidate for schizophrenia
June 28, 2013
FDA grants fast track designation to Genervon's GM-604 in ALS
June 27, 2013
QRxPharma provides update on MoxDuo NDA review
June 27, 2013
Boehringer Ingelheim designs novel mGlu5 receptor modulators
June 27, 2013
Previous
1
2
…
979
980
981
982
983
984
985
986
987
…
2788
2789
Next